期刊文献+

无功能垂体腺瘤与正常垂体中microRNAs的差异表达 被引量:6

Differential Expression of MicroRNAs in Nonfunctioning Pituitary Adenoma and Normal Pituitary
下载PDF
导出
摘要 【目的】检测微小分子RNA(microRNA,miRNA)在无功能垂体腺瘤(NFA)和正常垂体(NP)组织中的差异表达,探讨微小分子RNA在垂体腺瘤发生发展过程中的作用。【方法】收集6例NFA和6例NP,应用miRCURYTM LNA基因芯片技术分析差异表达的miRNA,并应用荧光定量PCR对部分差异表达的miRNA进行验证。【结果】与正常标本相比,肿瘤标本中miR-124、-141、-200c、-223、-297、-299-5p、-32、-340、-378、-491-3p、-519d、-525-5p、-550、-551a、-574-5p、-583、-662、-768-3p、-885-5p、-890等20个miRNAs显著上调(上调到>2.0倍),miR-125b-1、-132、-17、-192、-193a-3p、-193a-5p、-21、-302c、-30b、-31、-376b、-490-5p、-542-3p、-567、-622、-637、-654-3p、-658等18个miRNAs明显下调(下调到0.5倍以下)。一些差异表达的miRNA参与细胞的增殖和凋亡过程,提示它们的变化可能与垂体腺瘤的发生发展有关。【结论】miRNAs表达的变化可能参与无功能垂体腺瘤的发生,而miRNAs靶基因的确立可以为无功能垂体腺瘤的发生机制提供新的理论依据。 【Objective】 The purpose of this study was to identify different expression of miRNAs between nonfunctioning pituitary adenoma(NFP) and normal pituitary(NP),and investigate the role of miRNA in development and progression of pituitary adenomas.【Methods】 Six NFA and 6 NP were collected.The miRNAs in NFA and NP were analyzed by miRCURYTM LNA array and some differentially expressed miRNAs were confirmed by quantitative real-time PCR.【Results】 Compared with NP,20 microRNAs were significantly increased(fold change to more than 2.0) : miR-124,-141,-200c,-223,-297,-299-5p,-32,-340,-378,-491-3p,-519d,-525-5p,-550,-551a,-574-5p,-583,-662,-768-3p,-885-5p,and-890;Eighteen microRNAs including miR-125b-1,-132,-17,-192,-193a-3p,-193a-5p,-21,-302c,-30b,-31,-376b,-490-5p,-542-3p,-567,-622,-637,-654-3p,and-658 decreased significantly(fold change to less than 0.5) in NFAs.Several miRNAs identified in our study are involved in cell proliferation and apoptosis indicated their changes are associated with tumor development and progression.【Conclusion】 Our results demonstrated that altered miRNAs expression may be involved in NFAs transformation and the establishment of target genes of miRNAs may elucidate molecular mechanisms involved in the pathogenesis of pituitary adenomas.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2011年第1期26-30,共5页 Journal of Sun Yat-Sen University:Medical Sciences
基金 国家自然科学基金面上项目(30971538) 广东省自然科学基金(9151140004000001) 广东省科技计划项目(2007B031504002)
关键词 MICRORNA 无功能垂体腺瘤 垂体 基因芯片 差异表达 BCL-2 microRNA nonfunctioning pituitary adenoma pituitary gland microarray differential expression Bcl-2
  • 相关文献

参考文献21

  • 1Bartel DP.MicroRNAs:Genomics,biogenesis,mechanism,and function[J].Cell,2004,116(2):281-297.
  • 2Esquela KA,Slack FJ.Oncomirs-microRNAs with a role in cancer[J].Nature,2006,6(4):259-269.
  • 3Kloosterman WP,Plasterk RH.The diverse functions of microRNAs in animal development and disease[J].Dev Cell,2006,11(4):441-450.
  • 4Zhang B,Pan X,Cobb GP,et al.MicroRNAs as oncogenes and tumor suppressors[J].Dev Biol,2007,302(1):1-12.
  • 5Johnson CD,Esquela-Kerscher A,Stefani G,et al.The let-7 microRNA represses cell proliferation pathways in human cells[J].Cancer Res,2007,67(16):7713-7722.
  • 6Bottoni A,Piccin D,Tagliati F,et al.miR-15a and miR-16-1 downregulation in pituitary adenomas[J].J Cell Physiol,2005,204(1):280-285.
  • 7Qian ZR,Asa SL,Siomi H,et al.Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas[J].Mod Pathol,2009,22(3):431-441.
  • 8Amaral FC,Torres N,Saggioro F,et al.MicroRNAs differentially expressed in ACTH-secreting pituitary tumors[J].J Clin Endocrinol Metab,2009,94(1):320-323.
  • 9Chen C,Ridzon DA,Broomer AJ,et al.Real-time quantification of microRNAs by stem-loop RT-PCR[J].Nucleic Acids Res,2005,33(20):e179.
  • 10Garzon R,Fabbri M,Cimmino A,et al.MicroRNA expression and function in cancer[J].Trends Mol Med,2006,12(12):580-587.

同被引文献72

  • 1魏俊吉,张波,王任直,徐淑军,马文斌.侵袭性垂体腺瘤发病机制及诊断标准的研究进展[J].中国微侵袭神经外科杂志,2005,10(10):478-480. 被引量:13
  • 2温星桥,李小娟,罗云,王林,周祥福,蔡育彬,温机灵,高新.生育酚结合蛋白通过磷酸肌醇3激酶途径抑制前列腺癌的生长[J].中山大学学报(医学科学版),2007,28(4):367-372. 被引量:4
  • 3Semenzato G,Adami F, Maschio N,et al Immune mechanisms in interstitial lung deseaes.Allergy,2005,5:1103-1120.
  • 4Kreutzer J, Fahlbusch R.Diagnosis and reatment of pituitary tumors.Curren Opinion Neurol,2004,6:693-703.
  • 5Farell WE,Clayton RN,Mlecular.Pathogenesis of pituitary tumor,Front Neuroendocrinal,2000,3:174-198.
  • 6Molitch ME.Disorders of prolactin secretion.Endocrinol Metab Clin N Amer,2001,30:585-610.
  • 7Mindermann T, Wilson CB.Age-related and gender related occurrence of pituitary adenomas.Clin Endocrinol,1994,41:359-364.
  • 8Ciccarelli A,Daly AF,Beckers A.The epidemiology of prolactinomas.Pituitary,2005,8:3-6.
  • 9Azouzi M,Hsu DW,Black PM,et al.The importance of dopamine the pathogenesis of experimental prolactinomas.J Neurosurg,1990,72:273-281.
  • 10Heaney AP,Horwitz GA,Wang Z,et al.Early involvement of estro-gen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis.Nat Med,1999,5:1317-1321.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部